Supports basic and translational research to prevent coronary heart disease or circulatory failure, emphasizing innovation and impact at mid-sized U.S. institutions; clinical studies are excluded.
Funder: Harold S. Geneen Charitable Trust
Due Dates: July 7, 2026 (Full application submission deadline; applications due by 12:00 PM Eastern Time)
Funding Amounts: $250,000 total per award over two years (inclusive of up to 10% indirect costs); three awards expected per cycle
Summary: Supports basic and translational research on the prevention of coronary heart disease or circulatory failure at select mid-sized U.S. institutions.
Key Information: Clinical studies are ineligible; only invited institutions may apply; applicants must have less than $500,000 in direct research funding.
This program, administered by Health Resources in Action (HRiA), funds innovative basic and translational scientific research aimed at the prevention of coronary heart disease or circulatory failure, and the improvement of care for affected patients. The funder’s directive is to support research at smaller and mid-sized institutions, specifically excluding major universities and medical complexes with significant fundraising capacity. The program does not fund clinical studies.
Research projects should focus on advancing understanding, prevention, or treatment of coronary heart disease or circulatory failure. Emphasis is placed on scientific merit, innovation, and the potential for meaningful impact in the field.